Fate Therapeutics Inc (NASDAQ:FATE)

11.56
Delayed Data
As of 4:00pm ET
 +0.29 / +2.57%
Today’s Change
2.52
Today|||52-Week Range
14.45
+89.20%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close11.27
Today’s open11.27
Day’s range11.18 - 11.62
Volume472,938
Average volume (3 months)689,892
Market cap$484.2M
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+2.86%
Earnings growth (this year)-3.27%
Earnings growth (next 5 years)--
Revenue growth (last year)-6.72%
P/E ratioNM
Price/Sales62.47
Price/Book6.25

Competitors

 Today’s
change
Today’s
% change
VBIVVBI Vaccines Inc-0.19-5.97%
CGENCompugen Ltd+0.05+1.56%
VBLTVascular Biogenics L...-0.02-1.16%
KMDAKamada Ltd+0.10+2.06%
Data as of 4:00pm ET, 05/24/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$4.1M
Annual profit (last year)-$43.0M
Net profit margin-1,046.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
J. Scott Wolchko
Chief Scientific Officer
Daniel D. Shoemaker
Corporate headquarters
San Diego, California

Forecasts